Risdiplam is the only orally administered drug approved for that treatment of SMA. It was FDA permitted in 2020 to be used in people two months of age and older, and it features as an SMN2 gene splicing modifier leading to larger levels of SMN protein. Oral administration is a https://cyclosporine66442.jaiblogs.com/53573978/how-le-300-can-save-you-time-stress-and-money